'It's the perfect storm': Doctors urge measles vaccinations as Alberta case counts rise
As concerns about measles grow, and case counts tick up, health-care workers are preparing for a surge and pleading with Albertans to ensure they're fully vaccinated.
According to Alberta Health there were 13 confirmed cases in the province as of midday Tuesday, including two in the Calgary zone, three in the Edmonton zone and eight in the north zone.
That's an increase of two cases (one each in the Calgary and Edmonton zones) since Monday, when the province reported one person was hospitalized with the highly contagious virus.
While the province has yet to provide age ranges for the latest cases, as of Monday, the youngest Albertan confirmed with measles at this time is a baby under one year of age, and the oldest is an adult between the ages of 35 and 54.
According to Alberta Health, the age breakdown, as of Monday, was as follows:
Under one: 1 case
Ages 1-4: 3 cases
Ages 5 -9: 4 cases
Ages 10-14: 2 cases
Ages 35-54: 1 case
"I think we're just at the tip of the iceberg," said Dr. Sidd Thakore, a pediatrician at the Alberta Children's Hospital, who expects Alberta will see more cases in the next couple weeks.
"It's the perfect storm of a very contagious virus — that can last in the air or on surfaces — and with people that are not as vaccinated [as] before. I think we're going to see pockets of it increasing in the next one to two weeks."
In addition to being airborne, Thakore said the virus can also be difficult to contain because people can be contagious for up to four days before the rash appears.
He said Alberta Children's Hospital staff are preparing for more cases of a vaccine-preventable illness some of them have never had to deal with before.
"In the early 2000s you never heard about it. You never saw it," he said. "Now we're seeing it and we're going to have to deal with it. So my whole group in the hospital, we're just making sure we're up to date on what needs to be done."
Seeing Alberta's case count rise is frustrating for physicians, including Dr. Isabelle Chapados.
"This is 100 per cent preventable," said Chapados, a clinical assistant professor of pediatrics at the University of Alberta.
"It was written in the sky as rates of vaccination were coming down."
Alberta's routine childhood immunization schedule recommends children get two doses of the measles vaccine — the first at 12 months and the second at 18 months of age.
However, vaccination rates have been dropping.
Provincial data shows 69.3 per cent of Alberta children were fully vaccinated with two doses by the age of two in 2023, with some parts of the province dipping well below 50 per cent.
The target is 95 per cent.
Thakore is urging people to ensure they and their children are fully vaccinated. People who are unsure should talk to their health care provider, he said.
"It would be very unfortunate if you're not getting vaccinated because of false information," he said.
"The measles vaccine is a safe vaccine. And it works."
According to the Public Health Agency of Canada, the single MMR (measles, mumps, rubella) vaccine was introduced in the provinces between 1974 and 1983. The routine two-dose MMR vaccine was brought in nationally between 1996 and 1997.
The country saw a dramatic decrease in measles cases after the vaccine was introduced, and in 1998 the virus was considered "eliminated" in Canada because endemic transmission was no longer taking place.
Daily updates
Alberta's Health Minister, Adriana LaGrange, said the province is working to get information out to Albertans.
"We've seen vaccine hesitancy not just in Alberta, but right across Canada and globally. So we're giving the information out as much as possible," she said on Monday.
Alberta Health plans to start publishing a daily update on measles case counts on Tuesday. The numbers are expected to be updated at 12:30 p.m. from Monday to Friday.
When asked about whether or not she endorses two doses of the measles vaccine, LaGrange said she does.
"We continue to work with young families and make sure they have the information they need to make good choices for themselves and their families," LaGrange said.
Measles can be dangerous, leading to complications including swelling of the brain, pneumonia and even death, Alberta Health says.
"That's scary. So that's the risk we have to deal with and we may be facing ... over these next couple of weeks," said Thakore.
Between one and three in every 1,000 people who contract the virus will die, the province said. And more than 90 per cent of people who are not immune to measles and who come into contact with the virus will become infected.
Babies are among those most at risk, Chapados said, because they're not protected until after they get their second dose at 18 months.
"The only protection we have is to collectively all get our vaccinations done. Otherwise those babies are sitting ducks," she said.
Adults born before 1970 are likely immune because measles circulated widely at that time, according to the province. People born on or after 1970 are susceptible if they don't have two doses, AHS said.
Meanwhile, the province said it's aware of several separate and unrelated ways that measles was introduced into Alberta, noting it was brought in through an Ontario connection and through "at least two international sites."
The Alberta government's measles website provides more information on how the virus spreads, its symptoms, immunization and what to do if you think you may be infected.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Boston Globe
3 days ago
- Boston Globe
RFK Jr. wants to allow more experimental therapies, acknowledging health risks and threat of ‘charlatans'
'And of course you're going to get a lot of charlatans, and you're going to get people who have bad results,' he added. 'And ultimately, you can't prevent that either way. Leaving the whole thing in the hands of pharma is not working for us.' Advertisement Kennedy cited his own experience at a clinic in Antigua, where he said he received a stem cell treatment that 'enormously' eased his neurological condition, spasmodic dysphonia, which affects his voice and has few treatment options. Get Starting Point A guide through the most important stories of the morning, delivered Monday through Friday. Enter Email Sign Up If Kennedy does permit broader use of unauthorized or experimental therapies, he would be reversing long-standing efforts by the FDA to monitor and sometimes police the emerging field. Experts, including some who support alternative medicine, worry that without safeguards, an expansion of such treatments could undermine legitimate development of new therapies. The FDA now narrowly permits stem cell therapies to treat blood and immune disorders. Nearly a decade ago, the field was so loosely regulated that the agency pursued court actions to shut down rogue clinics using unauthorized treatments for a wide array of ailments. Some providers in the United States and in other countries continue to offer experimental stem cell therapies for everything from autism to Alzheimer's to erectile dysfunction. Advertisement The latest move reflects an expansion of Kennedy's drive to dismantle federal health policy to reflect his long-held views, which had so far focused mainly on vaccines, chronic diseases, food dyes and fluoride. A push to open up the field of unregulated stem cell infusions meshes with his oft-stated contention that the FDA is a 'sock puppet' for major drug companies and faces a crisis of distrust. Wellness industry products, he has claimed, are unfairly sidelined. A spokesperson for the Department of Health and Human Services did not respond to requests for comment. Kennedy's statements alarmed experts on the field of sometimes dangerous stem cell infusions -- who noted that many of Kennedy's allies endorse wellness products ranging from red-light therapy to magnetism. 'It's a complete abdication of protection of the public, letting these grifters go forward,' said Timothy Caulfield, a research chair in health law and policy at the University of Alberta in Canada. 'For him to say, 'There are problems with Big Pharma, so we want our opportunity to be bad actors too,' it doesn't make any sense.' One leading expert group, the International Society for Stem Cell Research, reviewed Kennedy's podcast statements and condemned the approach as potentially allowing products that are 'sometimes contaminated with pathogens and are often marketed with scientifically implausible claims.' 'It is critical that the FDA maintain its regulatory authority to protect Americans from these potentially harmful and deceptive products,' the society said in a statement. Advertisement On Thursday, a panelist appearing at an FDA meeting on cell and gene therapies raised a concern about 'snake oil' treatments. Dr. Vinay Prasad, the agency's director of the center for biologics evaluation research, responded, 'We have to regulate the bad actors. We can't let that taint what we do here at the FDA.' Kennedy, who also attended the event, voiced full support for the researchers and biotech executives working on gene therapies for rare diseases, including those who made history by creating a custom gene therapy for an infant named KJ. 'We're going to do everything in our power to sweep away the barriers from you getting those solutions to market and getting them funded, and do everything that we can to support you all,' Kennedy said. On Brecka's podcast in May, Kennedy cited other products that he'd like to see more of, including chelation treatment, which was discussed in a 2015 book edited by him that focused on widely debunked theories about mercury in vaccines and autism and cites 'evidence of chelation's benefits' from a few small studies. One 5-year-old Pennsylvania boy died in 2005 from cardiac arrest after a doctor tried to treat his autism with chelation. Neither Kennedy nor the FDA has released a formal plan to change agency standards for stem cell treatments, which have typically been reviewed by the agency as individual therapies to treat a specific disease. Widening overall access could also happen informally if the agency decided to relax enforcement, an approach the FDA used in the past to indicate that it wouldn't crack down on unauthorized products. During the pandemic, for example, the agency allowed providers to retrofit infusion pumps and ventilators to treat hordes of sick patients. Advertisement During the first Trump administration, the agency's commissioner, Dr. Scott Gottlieb, escalated enforcement against stem cell providers whom he described in 2017 as 'unscrupulous actors who have seized on the clinical promise of regenerative medicine.' The FDA followed through with lawsuits seeking to stop some stem cell providers, including one case that the government won on appeal in the fall. In that case, the agency alleged that one provider, the California Stem Cell Treatment Center, was offering a drug without FDA approval by taking stem cells from a person's fat, manipulating them and infusing them as a remedy for Alzheimer's disease, cancer and arthritis. The agency classifies stem cell treatments as a 'biologic' and approves them much like a drug after careful studies of safety and effectiveness. But the FDA does make exceptions: It does not regulate some treatments if providers say they are extracting and then reinserting a person's cells with minimal manipulation. In March, Kennedy convened a meeting with leaders in the stem cell field. Two people who attended said the gathering was a fact-finding effort to explore a safe way to increase access. To Dr. Noah Raizman, who attended the meeting on behalf of the American Academy of Orthopaedic Surgeons, Kennedy's new pronouncement 'sounds a little more casual and a little bit more emboldened.' In the podcast, Kennedy said that consumers should be able to navigate the industry's claims. 'We don't want to have the Wild West,' Kennedy said. 'We want to make sure that information is out there. But we also want to respect the intelligence of the American people -- the capacity of people who explore the outcomes that are going to benefit them the most.' Advertisement In recent years, stem cell treatments have caused harm in the United States and abroad. Experts at the Pew Research Center tallied more than 350 cases of side effects including life-threatening blood infections, heart attacks and tumors. One Boston neurosurgeon discovered a huge mass of bloody tissue in the lower spine of a man who had received unproven stem cell treatments in Mexico, China and Argentina. Three patients were blinded after stem cell treatments at a Florida clinic. The FDA prevailed in getting a court order to stop the clinic from operating. The field of stem cell treatments is so complex that the Harvard Medical School created a free course to help doctors navigate patient questions, said Insoo Hyun, the director of life sciences at the Museum of Science in Boston. More than 110 stem cell clinical studies are advancing under regulatory oversight. In one, scientists at the National Institutes of Health are using retinal cells developed from patients' blood to try to treat vision loss in older adults -- and follow them for 15 years. In another study aimed at helping patients with Parkinson's disease, researchers at a biotech company in California are exploring the safety of infusing dopamine-producing neurons in a region of the brain that controls the body's movements. A Chinese company is studying a treatment for heart failure that involves transplanting cardiac muscle cells into the heart. Some providers sidestep the costly, yearslong process of careful work that can lead to an FDA approval. Among them is Dr. Chadwick Prodromos, a Chicago doctor who offers stem cell treatments in Antigua. Kennedy welcomed him warmly at the March meeting, Raizman recalled. Reached for comment, Prodromos' office said that he was in Antigua doing treatments and was not available. Advertisement In an April interview on YouTube, Prodromos said that he was still in touch with the FDA about stem cell treatments that could help people 'without allowing scams and things that aren't valid. And you know, it's a tricky proposition.' A website for Prodromos' clinic says that he and colleagues offer injections in Antigua into the joints, back, neck, scalp, penis and pelvic floor for an array of conditions including autism, thinning hair and lupus. He uses AlloRX cells, which are derived from the umbilical cord, in a manner that in the United States would require an FDA-cleared clinical trial. People can seek out unregulated treatments using their own cells that are processed, purified and amplified in different ways. They can also find treatments using others' cells that vary widely in quality and sterility. Some low-quality clinics process cells in a back room, which is the opposite of a clinical-grade cell processing site. Hyun said he recently toured one in the Netherlands that used specialized air filtering, layers of gowns and a ban on bacteria-laden cellphones in their sterile area. 'It's kind of like you're entering a space station,' he said. Ultimately, Caulfield said, many unauthorized stem cell providers adopt the language of biotech and regenerative medicine, post glowing patient testimonials and exploit patients who are desperate for a cure. This article originally appeared in .
Yahoo
4 days ago
- Yahoo
AHS warns of another potential measles outbreak as total cases jumps to 724
Alberta Health Services is warning visitors to the University of Alberta Hospital that they may have come in contact with a person infected with measles. In a Tuesday news release, AHS warns that a person from outside Edmonton with a confirmed case of measles came to the city and was seen on May 28 between 7 p.m. and 9:45 p.m. at the foyer and information desk near the 112 Street entrance to the University of Alberta Hospital. AHS warns that anyone born in or after 1970 who has less than two measles vaccinations and came in contact with this person may be at risk of infection and should watch for the following symptoms: A fever of 38.3 C or higher Cough, runny nose and/or red eyes A red and blotchy rash that appears up to seven days after the fever starts, usually beginning behind the ears and on the face, spreading down to the body and then to the arms and legs. A dose of the measles vaccine must be administered within 72 hours of exposure to prevent infection. Babies under one year of age, people with severely weakened immune systems, and those who are pregnant may be able to receive immunoglobulin within six days of exposure to prevent disease. If you think you have been exposed and you are not protected against measles, you may be able to receive immunization. For more information, call the measles hotline at 1-844-944-3434 or text 'Measles' to 88111. This warning comes days after AHS warned of a person with measles visiting West Edmonton Mall and Fort Edmonton Park, which followed a previously confirmed case at a clinic in Spruce Grove. There are currently six known cases of measles infections in Edmonton. On Friday, AHS also issued a 'standing measles exposure advisory' for the entire south health zone. According to the AHS measles page, there are currently 724 known cases of measles in Alberta as of Tuesday, 14 of which are active infections. The south health zone bears the brunt of the infections, with 533, the majority of them between the ages of five and 17 years old. 'This standing advisory will replace the use of separate site-specific exposure advisories, which no longer accurately capture the scope of potential risk at this time,' AHS said in a written statement. The health agency noted it was tracking and managing a large number of measles cases in the area, 'including in individuals with no known exposure source,' it said. In early May, the Alberta government announced measures designed to increase vaccination rates and a public awareness campaign urging Albertans to get vaccinated. Recent visitor to Edmonton has measles: Alberta Health Services exposure alert Another measles alert for Edmonton area after case at Spruce Grove clinic
Hamilton Spectator
4 days ago
- Hamilton Spectator
New website looking for your health care stories
Albertans have a new online platform to share their lived experiences directly with the provincial health care system. Care Opinion initially launched 20 years ago in the United Kingdom to give citizens there an equal opportunity to tell stories regarding their personal health care – good or bad – and contribute to meaningful collaboration and change. debuted here in Alberta at the beginning of May. The website is operated by the non-profit, citizen-led Imagine Citizens Network (ICN). Patients across the province, or those with a close relationship to a patient, are being encouraged to submit stories that have happened within the last three years. Each story is carefully reviewed by a team of moderators, then posted to the Care Opinion Canada website along with searchable tags based on the themes included in the story, as well as the names of specific facilities, if they are provided. 'Our goal for Care Opinion is not meant to be a soapbox to complain, but rather be a safe place to contribute your story,' says Don McLeod, ICN executive director. 'The point is to tell your story and share your lived experience so that the system can learn and collectively we can make improvement happen in Alberta.' McLeod says he understands that some may struggle to trust the moderation process. However, he explains that the goal is to protect the confidentiality of patients and caregivers, and remove anything that might be considered discriminatory, slanderous or offensive without compromising the message at the heart of the story. A full statement of moderation principles is available on the Care Opinion Canada website. Each story is also assigned a criticality score between one and five, with five being the most critical. McLeod says care providers, whether they are subscribed to the service or not, are notified about every story and given an opportunity to either craft a response themselves or have Care Opinion Canada respond on their behalf. 'Everyone is always a little concerned about an online platform like this, but our moderation process is very constructive,' McLeod noted. 'Over 70 per cent of the stories over 20 years in the UK have been positive. The biggest impact of Care Opinion has been improving staff morale and focusing on what works well. In Alberta, we just crossed the first 100 story line, and already we have almost 80 per cent positive stories.' Several thousand care providers, including those across the local Chinook Primary Care Network, are already subscribed to Care Opinion Canada, with more being added all the time. McLeod told the Herald that subscribers must sign a two-year agreement, and the service can be customized based on the provider's needs. The website is receiving some financial support from Alberta Innovates and Alberta Health over the next three years, meaning that providers can access Care Opinion Canada for a minimal fee for the time being. McLeod hopes his organization will become more self-sufficient in the future, but this government funding will help with operating costs in the meantime. McLeod adds that the funding will not compromise the platform's commitment to be a neutral space for patient stories to be heard. 'The lived experiences of citizens, patients, family members and community members are important pieces of evidence to change the system. Our sole focus is to gather people to tell their stories and to make sure those stories get rolled into reports that inform policy changes at the system level, but also how programs and services are delivered at individual organizations. We value independence and we are also recognized as a trusted organization across the health system in Alberta. We write reports based on what we hear, not what the government wants to hear.' While there is still plenty of work to be done in Alberta, McLeod says Care Opinion Canada is already making connections with the other provinces and territories. He is hopeful that conversations will begin within the next year or two to launch the service in other parts of the country. Error! Sorry, there was an error processing your request. There was a problem with the recaptcha. Please try again. You may unsubscribe at any time. By signing up, you agree to our terms of use and privacy policy . This site is protected by reCAPTCHA and the Google privacy policy and terms of service apply. Want more of the latest from us? Sign up for more at our newsletter page .
